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ABSTRACT  Several  interferon  inducers  (Newcastle  disease  virus,  statolon,
and  poly rI: poly rC)  as well  as  exogenous  mouse  interferon  protect mice from
sporozoite-induced  Plasmodium berghei malaria,  as long  as they are administered
before  the  end  of the  preerythrocytic  phase  of  development  of  the  parasite.
The protective  effect  of the interferon  inducers was  related  to their interferon-
inducing effect;  the protective  effect  of the  interferon  preparations  was  related
to the  interferon  titer of the  preparations,  and  it exhibited  other  attributes of
interferon such as  species specificity.  In contrast to sporozoite-induced  infection,
blood forms-induced P. berghei malaria was  only weakly susceptible  to the pro-
tective  effect of interferon  inducers.  This difference  may provide  an  approach
to study  the mechanism  of protection.  The  growth in  cell cultures  of another
intracellular  protozoon,  Toxoplasma  gondii,  is  also  inhibited  by  interferon
(22).  The  fact that P. berghei and  T.  gondii  (as  well  as  another  group of in-
tracellular  parasites  susceptible  to  interferon,  the  Chlamydia) have  their  own
ribosomes  raises  questions,  concerning  the  role  of  host  cell ribosomes  in  the
host  cell-parasite  relationship  of  these  intracellular  parasites  and  in the me-
chanism of interferon action against them, that can  be approached  experiment-
ally.  The  possibility  of  therapeutic  or  prophylactic  application  of interferon
or of its inducers  to  certain  protozoal  diseases  of man  and  of  other  animals
is  still  remote,  but it  has  to  be  considered  for  long  range  planning.
The activity of interferon was initially thought to be limited to viral infections
(14).  Interference  phenomena  between  viruses  and  Protozoa  (31),  between
Chlamydia and Protozoa  (8),  and between  Eperythrozoon and Protozoa  (18,  19,
29) have  been reported,  but the possibility that they could have  been caused
by interferons was not considered.  Indeed,  it may be significant that the first
instance  in which interferon  was found to be effective  against  an agent other
than  a virus  occurred  with an  organism that was at the time believed  to be
a virus. In  1963, Sueltenfuss and Pollard (27)  reported that psittacosis  "virus"
was susceptible  to interferon. Just  about that time,  a consensus  was forming
among  microbiologists  that  organisms  of the  psittacosis-lymphogranuloma
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venereum-trachoma  group  had  many  properties  that  set  them  aside  from
viruses,  notably in  their mode  of reproduction,  and that they should  be in-
cluded into a different genus,  the Chlamydia (16).  This made the behavior  of
the  agent of psittacosis  anomalous with respect  to its  susceptibility  to  inter-
feron  and,  soon,  it was  found  that other  chlamydiae  such  as the  agents  of
trachoma  and  of inclusion  conjunctivities  were  also susceptible  to interferon
(4,  12,  15,  21).
By that time, it had  also been found  that several  agents other than viruses,
such as rickettsiae  (6,  13),  certain bacterias  (5,  26),  and some protozoa  (1,  7,
24)  were capable of inducing interferon,  thus raising  the question of the pos-
sible role of interferon in the natural history of diseases caused by these agents.
These  two  sets  of findings  led to  independent  studies  of the  effects  of inter-
ferons and interferon  inducers on other nonviral infections.  Two intracellular
protozoal  infections,  due  respectively  to  Toxoplasma  gondii  (22)  and  Plas-
modium berghei,l were found  to be susceptible to interferon.  Several protozoal
infections2'  3 (11,  25)  and bacterial  infections  (20,  30)  were affected by inter-
feron  inducers. Thus,  the spectrum  of action  of interferons  as well  as that of
interferon inducers appear to be broader than was formerly thought.
I shall first describe the main features of the effects  of interferon  and inter-
feron inducers on P. berghei malaria in mice and then discuss the implications
of these findings  and of studies from other laboratories  on  the mechanism  of
action of interferon inducers and interferon against protozoa and on potential
prophylactic and therapeutic  applications.
EFFECTS  OF  INTERFERON  INDUCERS  AND  OF  INTER-
FERON  ON  P.  BERGHEI  MALARIA  IN  MICE
The  system  has been  described  in  detail  elsewhere  (10),  and  only  its  main
features will be outlined. P. berghei can be maintained cyclically in the labora-
tory  (32)  so that infection of mice can be initiated either  with sporozoites  or
with  blood  forms.  Following  sporozoite  inoculation,  the  preerythrocytic
development  takes  place  in the  liver  in  hepatocytes  (32).  This phase of de-
velopment  is  completed  from 42  to  48  hr  after  inoculation  (28,  32)  when
tissue  merozoites  are  released  from  infected  hepatocytes.  Following  their
release from hepatocytes,  the merozoites enter red blood cells (RBC),  and the
erythrocytic  cycles  start.  Detectable  parasitemia  (patent  infection)  usually
develops between  4 and  6 days  after sporozoite  inoculation  (28).  Mice with
detectable  parasitemia almost invariably die of the infection, death occurring
'Jahiel,  R.,  J.  Vilek,  and R.  Nussenzweig.  Plasmodium berghei malaria: protection with  exogenous
interferon.  Manuscript  in preparation.
2 Actor,  P.,  D. Kunkle,  M.  Googe,  S.  Garg,  and J.  Pagano.  1969.  Inhibitory  effect  of interferon
inducers  on Leishmania donovani infection in mice.  Personal communication.
3 Herman, R.,  and  S. Baron.  1969.  The effects  of interferon inducers upon the intracellular  growth
of the protozoan parasite  Leishmania donovani. Personal communication.
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within a range of 7-35  days after  inoculation  (28).  The studies  on the effects
on interferon  inducers  and interferon,  performed with this system in my lab-
oratory,  were done in collaboration  with Doctors Jan Vilcek,  Ruth Nussenz-
weig,  and Jerome  Vanderberg,  and  Mr.  Steve  Levine,  a  medical  student.
All  experiments  were performed  with 4-wk-old  female  CF1  mice  (Carworth
Farms,  New  City,  N.Y.),  each  weighing  12-15  g.  The  interferon  inducers
were  Newcastle  disease  virus  (NDV),  statolon  (S),  and  the double-stranded
complex  of polyriboinosinic  and polyribocytidylic  acids  (poly rI:poly C). To
produce  mouse  serum  interferon,  mice  were  injected  with  NDV  and  bled
6-8 hr later; the serum was  dialyzed for 5 days against  a pH  2 buffer.  Inter-
feron levels were measured with a plaque reduction technique,  using vesicular
stomatitis  virus  and  mouse  L-cell  cultures  (10).  The  titer  of interferon  was
expressed  as the reciprocal  of the highest  dilution of the interferon prepara-
tion that caused at least 50% inhibition  of the control plaque count.
Sporozoite-Induced Infection
The  time  in relation  to sporozoite  inoculation  when  interferon  or interferon
inducers  were  given  was  critical  (9).1  The maximum  protective  effect  (Fig.
1) occurred  when interferon inducers  were given about 20 hr after sporozoite
inoculation.  The  protective  effect  (measured  by the  survival  rate,  an  index
of  strong  protection)  decreased  markedly  when  interferon  inducers  were
given later than 36 hr after inoculation. The protective  effect of mouse serum
interferon  was  significant  when  it  was  given  during  the  first  24  hr  after
inoculation  or just before  it; the protective  effect  (measured  by the survival
rate)  decreased when interferon  was given later than 36 hr after  inoculation.
When the mean number  of parasitized  RBC on the 6th day after inoculation
(an index which records moderate protection)  was used, the protective  effect
of interferon inducers and of interferon was found to decrease markedly when
they were given later than 42-48 hr after inoculation.
The most likely explanation  for these findings  is that the parasite  is either
more  susceptible or more accessible  to the effect of interferon  and its inducers
during  its  intrahepatic,  preerythrocytic  phase  of  development  than  during
its erythrocytic phase. A less likely alternative  is that interferon  or its inducers
interfer  (possibly  through  a  stimulation  of  the  reticuloendothelial  system)
with  the release  of the  parasite  from the liver  cell  and  the subsequent  inva-
sion of erythrocytes.
Role of Interferon in Protection Against Sporozoite-Induced Infection
Evidence  suggesting  that interferon  is the agent  in the interferon-containing
serum  which  is  responsible  for  protection  includes  the  following1:  (a)  the
relation  of the protective  effect of the serum  to its interferon titer (Table  I);
(b)  the  demonstration  that  a  similarly prepared  rabbit serum  interferon  of
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FIGURE  . Antimalarial  effect  of  interferon  inducers  and  of interferon  at  different
stages  of  development  of  P.  berghei.  Inoculation  of  5000  sporozoites  was  performed
intravenously  at zero  time.  A  single  injection  of  NDV  (109  p.f.u.),  statolon  (8  mg),
poly rI:poly  rC  (100  jig;  indicated  as poly  I:poly  C),  or  exogenous  mouse  serum
interferon  (about  4000 U)  was  given to each  mouse. The  control  range refers  to  the
mortality in mice inoculated  with sporozoites  and  injected  with  diluent  or  with  nor-
mal mouse  serum.  The  stage  of development  reached by  the parasite at various times
after  inoculation  is  shown  at the  top of the figure.
comparable  titer in rabbit cells  is without  protective  effect  against  infection
of  the  mouse';  (c)  the  demonstration  that  an  interferon  induced  in  mouse
L-cell  cultures by poly rI :poly rC has a protective effect  of the same magni-
tude  as that of a NDV-induced  mouse serum interferon  of comparable  titer;
and  (d)  the  resistance  of  the  protective  agent  to  prolonged  pH  2  dialysis.
These  findings  suggest  strongly that  interferon  is  the  agent in  mouse  serum
that protected mice against P. berghei malaria, but this point will not be com-
pletely established until this effect is demonstrated with purified preparations
of interferon.  Such studies  are now in progress.
Evidence  suggesting  that interferon  plays  a  role in  the protection  granted
by interferon inducers includes  (10):  (a)  the fact that three different inducers
(NDV,  S,  and  poly  rI:poly  rC)  protect  mice;  (b)  the  fact  that  sensitivity
to the protective  effect  of exogenous  mouse  serum  interferon  and  to  that of
interferon inducers decreases at about the same  time' (10);  (c) demonstration
-----------
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TABLEI
PROTECTION  AGAINST  SPOROZOITE-INDUCED  PLASMODIUM BERGHEI
MALARIA  WITH  EXOGENOUS  INTERFERON
Median number of parasitized
Death rate  RBC per  10,000 RBC on day 6
Number of interferon  Interferon-  AXpw  Interferon-
units injected per mouse  injected  group  Control group  (days)  injected  group  Control  group
10 X  10  5/8  8/8  +1.5$  14  348
7  X  103  3/8  8/8  +-1.1t  9  166
2  X  103  6/8  7/8  +l.Ot  45  485
9  X  102  8/8  8/8  +0.6  156  348
6  X  102  10/10  8/10  -0.1  90  97
Results  of four experiments  from Jahiel, Vilek,  and Nussenzweig.
1 Mice were  injected  with
5000 sporozoites  intravenously.  20-28 hr later,  groups  of mice were  injected  with interferon-
containing mouse serum  or with normal mouse serum (control groups).
* Appp,  mean prepatent  period  of interferon-injected  group minus mean  prepatent  period  of
control group.
P  <  0.01  with the t test.
that  procedures  which  decreased  the  interferon-inducing  effect  of statolon
(such  as  heating)  or  of  NDV  (centrifugation  at  100,000  g)  also  decreased
their protective  effect  and that  there  was a constant  relationship  in various
experimental  conditions  between  the  last  dilution  of  statolon  or  of NDV
which could induce  interferon and the last dilution of these agents which had
a protective effect (Table II)  (10).
While this  evidence suggests that at least part of the protection granted by
interferon inducers  is mediated through interferons,  it does not preclude the
possibility  that  additional  mechanisms  of  protection  may  also  be  involved.
Blood Forms-Induced Infection
Inoculation  of mice  with  infected  RBC  bypasses  the preerythrocytic  phase
of the infection,  and the erythrocytic  cycles  start right away.  Various  results
have  been  obtained  in  different  laboratories  using  different  experimental
conditions.  We  have  shown  (9,  10)  that  treatment  of mice  with  interferon
inducers  before  or  after  inoculation  with  blood  forms  causes  a  slight  but
significant  delay  in  occurrence  of detectable  parasitemia  and a  decrease  in
the number  of infected  RBC  on the  6th day  after  inoculation.  (Table  III).
We  have  not  yet  performed  studies  of  blood  forms-induced  infections  in
mice  treated  with  exogenous  interferon.  Schultz,  Huang,  and  Gordon  (25)
exposed P. berghei-infected RBC to normal serum or to interferon-containing
serum for periods of several hours in vitro and found that the cells exposed  to
interferon  were  no  longer  able  to  infect  mice.  However  purified  interferon
was not  used,  and  it is  possible  that the observed  effect  was  due to another
constituent  of  the  serum.  Geiman  and  Merigan  (T.  C.  Merigan,  personal
231  SINTERFERON  AND  INTERFERON  INDUCERS
TABLE II
SPOROZOITE-INDUCED  PLASMODIUM BERGHEI MALARIA:  PROTECTIVE
EFFECT AND  SERUM  INTERFERON-INDUCING  EFFECT OF NDV AND  STATOLON
Amount injected  %  dead  P  Range of serum IF* titers
NDV
p.f.u. 
None§  77.5  <40
2.0  X  104 - 2.2  X  104  80.0  <40
9.0  X  104 - 2.2  X  10r  77.511  <40
9.0  X  10  - 2.2  X  106  43.3  <0.01  <40
5.6  X  106-  2.2  X  107  21.7  <0.001  <40-40
1.0  X  108 - 1.0  X  109  10.0  <0.001  320-10,240
Statolon
mg
None¶  93.3  <40
0.08  80.0**  <40
0.8  35.0  <0.01  80
8  15.0  <0.001  160-320
Abstracted  from Tables  7 and 8, Jahiel, Nussenzweig, Vilcek, and Vanderberg  (10).  Mice were
inoculated with 5000 sporozoites  intravenously,  and they were injected 20 hr later with NDV-
infected  allantoic fluid  or with statolon,  diluted in physiological  saline,  or in  1%  sodium bi-
carbonate,  respectively.  All mice which died had previously  developed  parasitemia,  and none
of the mice which  developed  parasitemia  survived.  P was determined with the chi square test.
The  serum interferon  titer was measured  in blood samples  withdrawn  6  hr after  injection  of
NDV or 16 hr after injection  of statolon, since it had been shown  (see Table 6  in reference  10)
that these were  the times for peak interferon  titers  after injection of NDV or statolon,  respec-
tively.
* IF, interferon.
p.f.u.,  plaque-forming units.
§ Injected with normal allantoic fluid or with physiological  saline.
11  Prepatent  period not significantly prolonged.
¶ Injected with 1% sodium bicarbonate.
**  Significant  prolongation  of mean  prepatent  period;  excess  of mean  prepatent  period  over
that of the control  group was  1.8 days  (P, 0.001  with the t test).
communication),  working with infected RBC in vitro, found no difference  in
the  increase  in  number  of malarial  parasites  in  the  presence  or  absence  of
interferon.  In this system,  however,  multiplication  of the parasite occurs only
for a  period  of several  hours  at a  relatively  slow  rate,  i.e.,  it  is not clear  to
what  extent the multiplication  of the  parasite in this system  can be equated
to its multiplication in vivo.
Thus,  there  is  no  substantial  evidence  that interferon  has  any  protective
effect against  a blood forms-induced  infection  or any inhibitory effect  on the
development  of the parasite  in red  blood  cells.  The  slight  protective  effect
observed  with interferon inducers  could very well  be mediated by something
other than interferon. On the other hand, the possibility that interferon  exerts
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TABLE I
EFFECT  OF  NDV  OR  STATOLON  ON THE  INFECTION
OF  MICE INOCULATED  WITH  P.  BERGHEI BLOOD  FORMS
Mean No.  of parasitized  RBC per 10,000
Mean prepatent  period in days:  RBC on day 6§
Exp.  No.  Material injected*  ppp  P  x  p
1  NAF  4.2  155.0
NDV  5.0  <0.1  70.0  <0.05
Statolon  5.2  <0.05  116.5  <0.1
2  None  5.2  41.0
NDV  5.7  <0.1  4.3  <0.001
Statolon  6.0  <0.05  17.5  <0.01
Results  from Jahiel,  Nussenzweig,  Vilcek,  and Vanderberg  (10).  Mice were  inoculated  intra-
venously with  1000 P.  berghei infected RBC.  The number of mice per group was 10.  All mice in
each group developed detectable parasitemia and died.
* The injections were made 17-18 hr after inoculation. NAF, normal allantoic fluid.
t ppp, mean prepatent period; P,  significance with  the  test.
§ i,  mean  number  of parasitized RBC;  P,  significance  with the t test.
a slight  protective  effect  against blood  forms-induced  infection  has not been
ruled out either.
EFFECTS  OF  INTERFERON  AND  INTERFERON  INDUCERS
ON  OTHER  PROTOZOAL  INFECTIONS
Remington  and  Merigan  showed  in  1968  (22)  that  interferon  inhibits  the
cytopathic  effect  and formation  of plaques  in mouse  and  chick cell  systems.
Inhibition was  species-specific;  the activity  of the preparations  was  retained
after pH  2 dialysis  but lost  after heating at 800C or treatment with trypsin.
Several  purified preparations  were  tested for their antitoxoplasmic  and anti-
viral  effect, and there was consistently a direct relation between the activities
of the preparations  in the viral  assay  and that in the toxoplasma  assay.
The  effect  of interferon  inducers  on  Leishmania donovani infection  in  mice
has been studied by Actor  et al.2 and by Herman and Baron.3 The parasitic
load  of various cells  in liver and  spleen  was measured.  The results were  ex-
tremely  complex.3 This  suggested  that  several  mechanisms  may  have  been
acting at different times and in different organs. Furthermore when there was
a  protective effect,  there  was  no  correlation  with the interferon  titer of the
serum.  Thus, as the authors pointed out,3 there is at present no evidence that
interferon  is active  against L. donovani.  Cell culture  studies  with L.  donovani
also failed  to yield  such evidence.3
POSSIBLE  MECHANISMS
In view  of the lack of direct experimental  data bearing on the mechanism  in
experiments  with  protozoa,  the  still  rather  uncertain  status  of  proposed
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mechanisms  for the  antiviral  action  of  interferon  (2),  and  the  risk  inherent
in  applying  to  protozoal  infections  concepts  based  on  studies  done  with
viral infection,  this  section  must  necessarily  be  highly  speculative.  Its func-
tion  is not  to promote hypothetical  mechanisms but  merely  to  suggest  some
experimental  approaches with protozoa.
The  hypotheses  about  interferon  action  against  viruses  have had  to  take
into  account  the fact that the translation  of viral information  takes  place on
host  cell  ribosomes.  With  regard  to  intracellular  protozoal  infections,  this
is not the case  at first sight since both  T.  gondii and P.  berghei (3)  have their
own  ribosomes.  However,  the  participation  of  host  cell  ribosomes  in  these
systems  is  not  excluded  and  could  take  place  in  the  following  two  ways:
either  through permeability  of the protozoal  cell  membrane  to the protozoal
messenger  RNA and  to protozoal  proteins  synthesized  on  the host  cell  ribo-
somes,  or through  pinocytosis  or phagocytosis  of host  cell  ribosomes  by the
protozoon  with  continued  function  of  these  ribosomes  inside  the  protozoal
cell.  Pinocytosis  of host  cell material  by some  plasmodia  has  been  demon-
strated  (23).  Investigation  of these possibilities  with  tracer  experiments  and
electron  microscopic  studies,  respectively,  in the  systems  in which interferon
has been  shown to inhibit protozoal  infections  seems warranted.
The  present  emphasis  on interference  with  translation  and  on  ribosomal
modifications in current interferon  research should not deter investigations  of
possible  other  targets  of action  of interferon  or  interferon  inducers,  such  as
cell membrane,  lysosomes,  or mitochondrias.
Finally,  the well-known  stimulating  effect  of several  interferon  inducers,
such  as endotoxin  on the reticuloendothelial  system,  should be kept in mind
as  another  possible  major  mechanism  of  action  of  interferon  inducers  on
protozoa  in  vivo.  Indeed,  other  stimulants  of the  RE  system,  not  presently
known to stimulate interferon  formation,  such  as  Corynebacterium  parvum  (17),
have  a protective effect against sporozoite-induced  malaria.
POSSIBLE  APPLICATIONS
It  is of course premature to consider  applications  of either interferon  inducers
or interferon  to human or animal protozoal  diseases;  the toxicity of interferon
inducers  and the development  of less toxic derivatives  of the inducers requires
continued investigation.  Hyporeactivity  and  cross-hyporeactivity  to the  anti-
protozoal  effects  of interferon  inducers  must  be  better  defined.4 The  mass
production  of  human  interferon  appears  to be  feasible,  but it must  still  be
developed.  The effects  of interferon and of its inducers in protozoal  infections
require  further study.  So far,  the only species  in which  antiprotozoal  effects
4 Levine,  S., and  R. Jahiel. Antimalarial  effect of poly I :poly C in the mouse. Manuscript  in prepa-
ration.
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of interferon  inducers  and  of  interferon  have  been  demonstrated  in  vivo  is
the mouse.
Nevertheless,  since  a  protective  effect  has  been  demonstrated  in  some
systems,  the  potential  applications  of  interferon  and interferon  inducers  to
human  and  animal  protozoal  diseases  must  be  discussed.  The  potential
applications  fall into the following four classes.
(a)  Prophylactic  and therapeutic  use  in human  protozoal  infections,  such
as  toxoplasmosis  or  malaria.  There  are  several  drugs  which  are  effective
against  these  infections;  however,  problems  of  toxicity  and  of  development
of  resistance  warrant  studies  of  new  therapeutic  or  prophylactic  agents.
The  effectiveness  of interferon  or interferon  inducers  against  toxoplasmosis
should be studied in an in vivo  system, for  instance in the mouse. Next, con-
trolled  studies  of  the  effect  of  interferon  in  humans  with  congenital  toxo-
plasmosis  or  in  immunologically  deficient  individuals  with  toxoplasmosis,
designed  to compare the effectiveness  of human interferon  to that of current
therapeutic  agents,  would  be  in  order.  Since  the  protective  effect  against
experimental malaria  was most marked  when interferon  or its inducers were
given  during  the  preerythrocytic  phase  of  the  disease,  the most  promising
approach  to  human malaria  would  be the  use  of interferon  or  its  inducers
as prophylactic  agents.  This would  hinge  upon  the feasibility  of devising  a
regimen  for  the  administration  of  interferon  or  of interferon  inducers  that
would  be practical  and  effective  and  that would  avoid  the development  of
hyporeactivity  and of chronic  toxicity.
(b)  Use  in  conjunction  with another  type of  therapeutic  or prophylactic
agent.  The  low  protective  activity  of  interferon  inducers  when  they  are
administered during the erythrocytic  phase  of P. berghei malaria  should  not
deter  investigators  from  studying  the  effect  of  administering  interferon  or
interferon  inducers  together  with  other  prophylactic  or  therapeutic  anti-
malarial  agents in order to detect synergistic  combinations.
(c)  Use  in  treatment  of mammals  and birds  who  are  hosts  for protozoa
causing human diseases.
(d)  Use in  prophylaxis  or  treatment  of protozoal  infections  of veterinary
importance.  The first step  in these studies may be to survey the known intra-
cellular  protozoal  infections  of  mammals  and  birds  for  their  sensitivity  to
interferon  or its inducers.
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